Notably, loss of either ASCL1 or OLIG2 had only modest effects on tumor progression and survival, likely due to redundant functions of these two transcription factors given their extensive shared binding in GBMs (Fig. 1). This evidence concerns the gene OLIG2 and neoplasm.